Month: July 2024

Earlier in May, the board of the natural resources major had approved fund raising of up to ₹8,500 crore, which then got shareholder approval in June. The company could, however, raise a lower amount of around ₹6,000 crore, the people said. A final decision on the quantum of the share issue has yet to be taken.

Technical charts, options data, and India VIX levels suggest possible consolidation for the Nifty within the 23,200-23,600 range this week. If the index anages to close decisively above 23,500, it could move towards 24,000, analysts said. M&M, TVS Motors, Bharti, Indian Hotels, ICICI Lombard, Cipla, JB Chemicals, harmabees, and Hindustan Zinc are some of the stocks recommended by the analysts for trading.

Sachin Trivedi analyzes Nifty 50 earnings growth, PSU banks\’ performance, and sector preferences for FY25. Highlights include select private sector banks, two-wheeler segment, and healthcare space. Trivedi further says that in the long run, markets adjust to earning delivery and valuation. Therefore, investors need to moderate return expectations from the market.

Sanjiv Bhasin suggests holding RattanIndia for further gains. His top picks include Embassy Office and Wipro, with potential gains to Rs 450 and Rs 700, respectively. Zydus and Lupin stand out in pharma, while Zee remains an avoid due to management issues.

Sanjiv Bhasin suggests focusing on Marico, Nestle, Hindustan Lever as top FMCG picks, adding Godrej Consumer. Largecap private banks like HDFC, ICICI, Kotak, Axis, IndusInd are recommended amidst various market dynamics and sector-specific opportunities. Bhasin says the wealth effect means real estate is the real play. Along with that, FMCG and IT will now be more defensive with pharma as a constituent for the index till the results.